the opioid epidemic: a pharmacist’s perspective...the opioid epidemic: a pharmacist’s...
TRANSCRIPT
![Page 1: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/1.jpg)
The Opioid Epidemic: A Pharmacist’s Perspective
Jocelyn Kerl, PharmD., BCPS
Clinical Services Manager, National CooperativeRx
July 24, 2018
1nationalcooperativerx.com
![Page 2: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/2.jpg)
Controlled Substances
• Drugs whose manufacture, possession, or use is regulated by the government
• Drugs that have the potential for addiction and abuse
• Drugs that must be controlled to promote public health, safety, and welfare
nationalcooperativerx.com 2
![Page 3: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/3.jpg)
Controlled Substance: Federal Regulation
• 1970 Controlled Substance Act • Closed system
• Drug Enforcement Administration (DEA)• Scheduling substances, closed system registration
• Food and Drug Administration (FDA)• Drug approval, abuse potential
nationalcooperativerx.com 3
![Page 4: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/4.jpg)
nationalcooperativerx.com 4
![Page 5: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/5.jpg)
Controlled Substances: State Regulation
• Scheduling substances• Should be the same or more strict than federal law, but exceptions exist
• Dispensing and prescribing restrictions
• Electronic prescribing restrictions
• Prescription Drug Monitoring Programs (PDMPs)
nationalcooperativerx.com 5
![Page 6: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/6.jpg)
Controlled Substances: Schedules
• Schedules include I-V• Schedule I: no medical use
• Schedule II-V: approved medical uses with various limitations and restrictions
• Scheduling applies to opioids and some non-opioid medications
nationalcooperativerx.com 6
![Page 7: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/7.jpg)
Controlled Substances: Schedules*
• Schedule I; e.g. heroin, marijuana
• Schedule II; e.g. hydrocodone, oxycodone
• Schedule III; e.g. Tylenol with codeine®, Suboxone®
• Schedule IV; tramadol, benzodiazepines
• Schedule V; Sudafed®, some codeine cough syrups
Abu
se p
oten
tial
Regulation
*According to WI Chapter 961
nationalcooperativerx.com 7
![Page 8: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/8.jpg)
Recent Federal Legislation • Pharmacists have the responsibility to ensure that a
prescription is legal and not for purposes of abuse October 2010
Corresponding Responsibility
• Disposal options for opioids were expanded to include mail back programs, collection receptacles and take back events
October 2014
Secure and Responsible Drug Disposal Act
• Funding to increase preventive programs and availability of treatment
July 2016
Comprehensive Addiction and Recovery Act
• Created grants to fight opioid epidemic by funding PDMPs, addiction training for providers, increased accessibility to pain programs
December 2016
21st Century Cures Act
nationalcooperativerx.com 8
United States Department of Justice Drug Enforcement Administration. Title 21 Code of Federal Regulation Part 1306, 1311, and 1317.Congress.gov S.524 and H.R.34, available online
![Page 9: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/9.jpg)
Key Recent WI Legislation
• 2013 HOPE (Heroin and Opioid Prevention and Education) Agenda• Improved drug disposal options
• Allowed for opioid antidote administration by community members
• Required patients show identification to pick up certain controlled substances
• Offered criminal protection for those assisting someone during an overdose
• 2014 HOPE Agenda • Expanded existing treatment programs and created pilot treatment programs
• Strengthened punishment for habitual drug offenders
Jackson, Lauren. (2018). Legislation to Combat the Opioid Crisis in Wisconsin [PDF file].
Madison, WI. Wisconsin Legislative Reference Bureau. Retrieved from https://docs.legis.wisconsin.gov/misc/lrb/lrb_reports/lrb_reports_2_6.pdf
nationalcooperativerx.com 9
![Page 10: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/10.jpg)
Key Recent WI Legislation
Jackson, Lauren. (2018). Legislation to Combat the Opioid Crisis in Wisconsin [PDF file].
Madison, WI. Wisconsin Legislative Reference Bureau. Retrieved from https://docs.legis.wisconsin.gov/misc/lrb/lrb_reports/lrb_reports_2_6.pdf
• 2015 HOPE Agenda • Further expanded opioid antidote access
• Increased PDMP requirements for prescribers and pharmacies
• Increased state oversight of pain clinics
• Required annual reporting from methadone clinics
• Controlled substance board must report PDMP data
• Allowed boards to draft opioid best practice guidelines
• Further expansion of treatment options
• Prohibited the use of masking agents to pass drug tests
nationalcooperativerx.com 10
![Page 11: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/11.jpg)
Prescription Drug Monitoring Programs (PDMP)
• Electronic database that tracks controlled substance prescriptions
• All US states have an operational program except Missouri
nationalcooperativerx.com 11
![Page 12: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/12.jpg)
PDMP — WI Example
• Jun. 2010: Legislation to create PDMP
• Jan. 2013: PDMP begins collecting data
• Oct. 2013: WI begins sharing data with select states
• Jan. 2017: Enhanced PDMP launched (ePDMP)
• Apr. 2017: Several new PDMP requirements and features • Dispensers must document name of person receiving prescription
• Dispensers must submit data within one business day
• Prescribers must review PDMP prior to writing a prescription for a controlled substance
• Law enforcement and non-prescriber access
nationalcooperativerx.com 12
![Page 13: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/13.jpg)
PDMP — WI Example
• Oct. 2017: Interactive Public Statistics Dashboard
pdmp.wi.gov 1. click statistics in lower left corner
2. statistics archive
nationalcooperativerx.com 13
![Page 14: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/14.jpg)
WI PDMP Public Statistics
nationalcooperativerx.com 14
![Page 15: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/15.jpg)
WI PDMP Public Statistics
nationalcooperativerx.com 15
![Page 16: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/16.jpg)
WI PDMP Public Statistics
nationalcooperativerx.com 16
![Page 17: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/17.jpg)
Naloxone for Opioid Reversal
• Naloxone • Safe, effective, specific
• Injection or nasal spray
• Available without a patient-specific prescription• Those at risk for overdose
• Those in a position to assist someone at risk of overdose• Insurance cannot be billed
nationalcooperativerx.com 17
![Page 18: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/18.jpg)
Where to Find Naloxone
• Department of Health and Human Services• dhs.wisconsin.gov/opioids/standing-order.htm
• AIDS Resource Center
nationalcooperativerx.com 18
![Page 19: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/19.jpg)
Naloxone Prescribing Recommendations
• 2016 Centers for Disease Control • History of overdose
• History of substance abuse
• High dose opioids
• Also taking benzodiazepines
• WI Medical Examining Board • History of overdose
• High dose opioids
• Clinical depression
• Evidence of increased risk
nationalcooperativerx.com 19
![Page 20: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/20.jpg)
How Much Does Naloxone Cost?National CooperativeRx Average AWP July 2017 — June 2018
AWP: $6,150
AWP: $75 AWP: $40
AWP: $20
nationalcooperativerx.com 20
![Page 21: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/21.jpg)
Naloxone Coverage Considerations
• Needles/Syringes
• IV Injectables
• Evzio
nationalcooperativerx.com 21
![Page 22: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/22.jpg)
Opioid Coverage ConsiderationsNational CooperativeRx February-June claims
Utilization Management• Improved access to medications for the treatment of opioid abuse
• Initial fill limitations
• Quantity limitations
• Step therapy
Year Avg. Eligible
Members/mo.
Total Opioid
Rx
Total Opioid
Utilizers
Percent Opioid
Utilizers
2018 284,890 41,775 18,884 6.6%
2017 252,389 43,637 19,370 7.7%
nationalcooperativerx.com 22
![Page 23: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/23.jpg)
Opioid Disposal
• Drug Take Back Days
• Local Police Departments
• Mail Back Programs
• WI Drug Repository
• Sharps
nationalcooperativerx.com 23
![Page 24: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/24.jpg)
Employer Considerations
• Evaluate your company’s drug policy
• Consider including prescription medications in your company’s drug testing program
• Educate employees:• Risks of driving or operating machinery
• Non-opioid treatment options
• Proper storage and disposal
• Train supervisors and managers
• Consider an onsite naloxone kit
nationalcooperativerx.com 24
![Page 25: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/25.jpg)
Employer Resources
• WI Department of Health and Human Services • Prevention and Healthy Living Opioid Resources • dhs.wisconsin.gov• English & Spanish Handouts
• Opioid safety, naloxone education, general resource guide
• Dose of Reality • doseofrealitywi.gov• Get Support Businesses • Disposal location interactive map• Sharps disposal resources • Order educational materials
nationalcooperativerx.com 25
![Page 26: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/26.jpg)
Questions?
nationalcooperativerx.com 26
![Page 27: The Opioid Epidemic: A Pharmacist’s Perspective...The Opioid Epidemic: A Pharmacist’s Perspective Jocelyn Kerl, PharmD., BCPS Clinical Services Manager, National CooperativeRx](https://reader036.vdocuments.site/reader036/viewer/2022071021/5fd559f577f77e4e6a6a7613/html5/thumbnails/27.jpg)
Thank You
nationalcooperativerx.com 27
Jocelyn Kerl, PharmD., BCPSClinical Services Manager